321 related articles for article (PubMed ID: 17638891)
1. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
[TBL] [Abstract][Full Text] [Related]
2. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
[TBL] [Abstract][Full Text] [Related]
3. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
Patrawala L; Calhoun T; Schneider-Broussard R; Li H; Bhatia B; Tang S; Reilly JG; Chandra D; Zhou J; Claypool K; Coghlan L; Tang DG
Oncogene; 2006 Mar; 25(12):1696-708. PubMed ID: 16449977
[TBL] [Abstract][Full Text] [Related]
4. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
6. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C
Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491
[TBL] [Abstract][Full Text] [Related]
8. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
9. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Chauchereau A; Al Nakouzi N; Gaudin C; Le Moulec S; Compagno D; Auger N; Bénard J; Opolon P; Rozet F; Validire P; Fromont G; Fizazi K
Exp Cell Res; 2011 Feb; 317(3):262-75. PubMed ID: 20974126
[TBL] [Abstract][Full Text] [Related]
10. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
[TBL] [Abstract][Full Text] [Related]
11. Brief report: a bioassay to identify primary human prostate cancer repopulating cells.
Toivanen R; Berman DM; Wang H; Pedersen J; Frydenberg M; Meeker AK; Ellem SJ; Risbridger GP; Taylor RA
Stem Cells; 2011 Aug; 29(8):1310-4. PubMed ID: 21674698
[TBL] [Abstract][Full Text] [Related]
12. Evidence for cancer stem cells in human endometrial carcinoma.
Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of cancer stem cells in human prostate cancer cells.
Lee EK; Cho H; Kim CW
Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a subpopulation of colon cancer cells with stem cell-like properties.
Chu P; Clanton DJ; Snipas TS; Lee J; Mitchell E; Nguyen ML; Hare E; Peach RJ
Int J Cancer; 2009 Mar; 124(6):1312-21. PubMed ID: 19072981
[TBL] [Abstract][Full Text] [Related]
15. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
16. Potent oncolytic activity of human enteroviruses against human prostate cancer.
Berry LJ; Au GG; Barry RD; Shafren DR
Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643
[TBL] [Abstract][Full Text] [Related]
17. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
[TBL] [Abstract][Full Text] [Related]
18. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
19. Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis.
Santamaria-Martínez A; Barquinero J; Barbosa-Desongles A; Hurtado A; Pinós T; Seoane J; Poupon MF; Morote J; Reventós J; Munell F
Exp Cell Res; 2009 Oct; 315(17):3004-13. PubMed ID: 19447103
[TBL] [Abstract][Full Text] [Related]
20. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
Gao AC; Lou W; Sleeman JP; Isaacs JT
Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]